Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)

Affiliations

• ¹ Hôpital Saint Louis, Université Paris Diderot, France.
• ² Hospices Civils de Lyon, Département d'Hématologie, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.
• ³ Hematology Department, Nancy University Hospital, France.
• ⁴ Hematology Department, Bordeaux University Hospital, France.
• ⁵ Institut Paoli Calmette, Marseille, France.
• ⁶ Hematology Department, Versailles University Hospital, France.
• ⁷ Hematology Department, University of Lausanne, CHUV, Switzerland.
• ⁸ Deparment of Clinical and Experimental Hematology, Institut Jules Bordet (ULB), Brussels, Belgium.
• ⁹ Hematology Department, Amiens University Hospital, France.
• ¹⁰ Hematology Department, Caen University Hospital, France.
• ¹¹ Hematology Department, Limoges University Hospital, France.
• ¹² Service de Biostatistique et Information médicale, Hôpital Saint Louis, Université Paris Diderot, France.
• ¹³ Hôpital Saint Louis, Université Paris Diderot, France pierre.fenaux@aphp.fr.